Vanguard Group »

Pasithea Therapeutics Corp shares owned by Vanguard Group

Quarter-by-quarter ownership of Pasithea Therapeutics Corp (KTTA) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Pasithea Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Pasithea Therapeutics Corp held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pasithea Therapeutics Corp by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $126k 98k 1.29
2025-09-30 $39k 54k 0.72

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)

View all positions for Vanguard Group

Top funds holding Pasithea Therapeutics Corp

Vivo Capital
Cable Car Capital
Longwood Capital Partners
Stempoint Capital
AdvisorShares Investments
Stonepine Capital Management
Vanguard Group
Citadel Advisors
Jane Street
Geode Capital Management
Two Sigma Investments
Northern Trust
XTX Topco
UBS Group
Hurley Capital

View all funds holding Pasithea Therapeutics Corp